Well, now we know. On the plus side (if there is such a thing) the total cost of this adventure is about USD2m to BYE or less than one months revenue from SM71.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025